Clinton Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-28,707
Closed -$932K 880
2016
Q2
$932K Buy
+28,707
New +$932K 0.04% 507